Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384199692> ?p ?o ?g. }
- W4384199692 abstract "Background The idea of psoriatic disease continuum has been progressively prompted based on the advances of the knowledge about the pathogenic steps underpinning the occurrence of psoriasis (PSO) and psoriatic arthritis (PSA). To evaluate biomolecules (inflammatory cytokines, inflammatory chemokines, cell adhesion and cellular mediators) in naïve patients with PSO, PSA with PSO, and PSA sine PSO. To stratify the results considering the presence of psoriatic nail involvement, extensive skin disease and obesity evaluating all involved patients. Methods By multiplex technology, 20 serum biomolecules were assessed with the inclusion of pro-inflammatory cytokines (GM-CSF, IFN-γ, IL-1α, IL-1β, IL-6, IL-8, IL-12p70, IL-17A, IL-23, TNF), anti-inflammatory cytokines (IFN-α, IL-4, IL-10, IL-13), inflammatory chemokines (IP-10, MCP-1, MIP-1α, MIP-1β), cell adhesion and cellular mediators (ICAM-1, E-selectin, P-selectin). The assessment of possible statistical differences between the means of the three groups was performed by One-Way ANOVA. In addition, by non-parametric T-tests, we stratified the results according to selected clinical characteristics (psoriatic nail involvement, PASI ≥ 10, BMI ≥ 30). Results In 80 assessed naïve patients, patients with PSO showed significant increases of E-selectin (p=0.021) and IL-8 (0.041) than other groups. In patients with PSA with PSO, significant higher levels of ICAM-1 were observed (p=0.009) than other groups. We did not observe further differences comparing pro-inflammatory and anti-inflammatory cytokines, inflammatory chemokines, and cell adhesion and cellular mediators in patients with PSO, PSA with PSO, and PSA sine PSO. Patients with psoriatic onychopathy showed significant increased levels of ICAM-1 (p=0.010) and IP-10 (0.030) than others. In patients with PASI ≥ 10, significantly enhanced values of IL-8 (p=0.004), TNF (p=0.013), E-selectin (p=0.004), MIP-1α (p=0.003), and MIP-1β (p=0.039). In patients with BMI ≥ 30, significantly higher levels of E-selectin were pointed out (p=0.035) than others. Conclusion Our findings may suggest that a similar cytokine profile may characterize naïve patients with PSO, PSA with PSO, and PSA sine PSO, reinforcing the concept of psoriatic disease continuum. However, some differences may be also shown, underlying possible pathogenic differences and leading to the clinical heterogeneity of these patients." @default.
- W4384199692 created "2023-07-14" @default.
- W4384199692 creator A5014762006 @default.
- W4384199692 creator A5021496401 @default.
- W4384199692 creator A5023519590 @default.
- W4384199692 creator A5030868203 @default.
- W4384199692 creator A5051877703 @default.
- W4384199692 creator A5055362200 @default.
- W4384199692 creator A5059801329 @default.
- W4384199692 creator A5065162801 @default.
- W4384199692 creator A5085007757 @default.
- W4384199692 creator A5085554542 @default.
- W4384199692 date "2023-07-13" @default.
- W4384199692 modified "2023-09-26" @default.
- W4384199692 title "Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum" @default.
- W4384199692 cites W1973302470 @default.
- W4384199692 cites W1977857378 @default.
- W4384199692 cites W2010417263 @default.
- W4384199692 cites W2010653146 @default.
- W4384199692 cites W2067327580 @default.
- W4384199692 cites W2083180635 @default.
- W4384199692 cites W2120422600 @default.
- W4384199692 cites W2143051004 @default.
- W4384199692 cites W2154286198 @default.
- W4384199692 cites W2157432727 @default.
- W4384199692 cites W2170374008 @default.
- W4384199692 cites W2557998737 @default.
- W4384199692 cites W2912335857 @default.
- W4384199692 cites W2988330068 @default.
- W4384199692 cites W2988659325 @default.
- W4384199692 cites W2990452769 @default.
- W4384199692 cites W3005573391 @default.
- W4384199692 cites W3129490578 @default.
- W4384199692 cites W3170657268 @default.
- W4384199692 cites W3202507436 @default.
- W4384199692 cites W4224987261 @default.
- W4384199692 cites W4228997515 @default.
- W4384199692 cites W4289841180 @default.
- W4384199692 cites W4291145894 @default.
- W4384199692 cites W4298616011 @default.
- W4384199692 cites W4306784104 @default.
- W4384199692 cites W4308122978 @default.
- W4384199692 cites W4312160292 @default.
- W4384199692 cites W4317938281 @default.
- W4384199692 cites W4318777402 @default.
- W4384199692 cites W4323044020 @default.
- W4384199692 cites W4361303385 @default.
- W4384199692 cites W4362602623 @default.
- W4384199692 cites W4366237949 @default.
- W4384199692 cites W4379984509 @default.
- W4384199692 doi "https://doi.org/10.3389/fimmu.2023.1229516" @default.
- W4384199692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37520537" @default.
- W4384199692 hasPublicationYear "2023" @default.
- W4384199692 type Work @default.
- W4384199692 citedByCount "0" @default.
- W4384199692 crossrefType "journal-article" @default.
- W4384199692 hasAuthorship W4384199692A5014762006 @default.
- W4384199692 hasAuthorship W4384199692A5021496401 @default.
- W4384199692 hasAuthorship W4384199692A5023519590 @default.
- W4384199692 hasAuthorship W4384199692A5030868203 @default.
- W4384199692 hasAuthorship W4384199692A5051877703 @default.
- W4384199692 hasAuthorship W4384199692A5055362200 @default.
- W4384199692 hasAuthorship W4384199692A5059801329 @default.
- W4384199692 hasAuthorship W4384199692A5065162801 @default.
- W4384199692 hasAuthorship W4384199692A5085007757 @default.
- W4384199692 hasAuthorship W4384199692A5085554542 @default.
- W4384199692 hasBestOaLocation W43841996921 @default.
- W4384199692 hasConcept C13373296 @default.
- W4384199692 hasConcept C164027704 @default.
- W4384199692 hasConcept C203014093 @default.
- W4384199692 hasConcept C2776260265 @default.
- W4384199692 hasConcept C2776914184 @default.
- W4384199692 hasConcept C2778690821 @default.
- W4384199692 hasConcept C2780564577 @default.
- W4384199692 hasConcept C71924100 @default.
- W4384199692 hasConceptScore W4384199692C13373296 @default.
- W4384199692 hasConceptScore W4384199692C164027704 @default.
- W4384199692 hasConceptScore W4384199692C203014093 @default.
- W4384199692 hasConceptScore W4384199692C2776260265 @default.
- W4384199692 hasConceptScore W4384199692C2776914184 @default.
- W4384199692 hasConceptScore W4384199692C2778690821 @default.
- W4384199692 hasConceptScore W4384199692C2780564577 @default.
- W4384199692 hasConceptScore W4384199692C71924100 @default.
- W4384199692 hasFunder F4320323718 @default.
- W4384199692 hasLocation W43841996921 @default.
- W4384199692 hasLocation W43841996922 @default.
- W4384199692 hasLocation W43841996923 @default.
- W4384199692 hasOpenAccess W4384199692 @default.
- W4384199692 hasPrimaryLocation W43841996921 @default.
- W4384199692 hasRelatedWork W1994780675 @default.
- W4384199692 hasRelatedWork W2070463916 @default.
- W4384199692 hasRelatedWork W2116137306 @default.
- W4384199692 hasRelatedWork W2126005292 @default.
- W4384199692 hasRelatedWork W2153718135 @default.
- W4384199692 hasRelatedWork W2181868919 @default.
- W4384199692 hasRelatedWork W2460795129 @default.
- W4384199692 hasRelatedWork W2510134963 @default.
- W4384199692 hasRelatedWork W2891088723 @default.
- W4384199692 hasRelatedWork W2102532225 @default.
- W4384199692 hasVolume "14" @default.